The yersiniabactin pathogenicity island of pathobiont E. coli promotes fibrosis in Il10-/- mice by Moore, Lyndsey
Introduction 
  
Inflammatory bowel diseases (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), are 
characterized by chronic inflammation and dysregulated immune responses elicited by dysbiosis of 
the gut microbiota.1 Normal wound healing mechanisms respond to injury by replacing damaged cells 
and excreting ECM to facilitate tissue repair; the repair process depends on the balance between 
ECM production and degradation.2 In patients with IBD, bowel injury elicits a chronic inflammatory 
response, which subsequently triggers fibrogenesis.3 Following tissue injury, mesenchymal cells 
(responsible for ECM production) become activated and proliferate due to interactions between 
paracrine and autocrine factors.2,3 These profibrotic mediators derive from interactions between the 
immune system, intestinal microbiota, epithelial cells, ECM, and mesenchymal cells.2 Fibrosis 
develops when mesenchymal cells (myofibroblasts, fibroblasts, and smooth muscle cells) become 
over activated and cause excessive ECM deposition without balanced degradation, resulting in 
regulatory failure.2,3,4 Intestinal fibrosis is a major complication associated with IBD; a ramification of 
chronic inflammation, fibrosis is characterized by excessive extracellular matrix (ECM) deposition and 
architectural distortion of the colon.2,3 Fibrosis ultimately affects at least 40% of patients with CD and 
5% of patients with UC.3,4 In many cases, fibrosis results in intestinal stricture formation which lead to 
bowel obstructions, the main reason for surgical intervention.2,3 Current treatment options primarily 
involve anti-inflammatory drugs and surgical interventions, but they are inadequate and recurrent 
symptoms are common.3,4 The deficits in therapeutic options are largely due to lack of relevant 
animal models and insufficient knowledge regarding the cellular and molecular pathways involved in 
the development of fibrosis.3,4  
 
Dysbiosis of the microbiota is largely implicated in the development of IBD, and evidence supports 
the implication of the gut microbiota in fibrogenesis as well.4 The IBD microbiome, as a consequence 
of inflammation,  is typically characterized by a decrease in microbial diversity alongside an increase 
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in aggressive species.1 One group of bacteria in particular, adherent-invasive Escherichia coli (AIEC), 
is overrepresented in the guts of both humans with IBD and animal models of colitis compared to 
healthy individuals.1 AIEC are capable of instigating and propagating chronic intestinal 
inflammation.1,5,6 
 
AIEC have several putative virulence factors, one being the yersiniabactin (Ybt) high pathogenicity 
island (HPI), which is overrepresented in AIEC strains.7 Many gut resident Enterobacteriaceae 
contain this HPI, it encodes proteins for the biosynthesis of the siderophore Ybt and its cognate 
receptor, FyuA.8 Once secreted by the bacteria, Ybt chelates Fe3+and other metals for bacterial metal 
acquisition.8,9 Metals like iron and copper are essential for both host and bacterial growth, but 
bacteria are often subjected to metal-limiting conditions within a mammalian host. This leads to the 
upregulation of high-affinity metal uptake systems like Ybt-FyuA, a system implicated in both 
virulence and bacterial fitness.10,11 Once secreted Ybt is bound to a metal, FyuA is required for Ybt-
metal import by the bacteria.9 While the Ybt-FyuA system is overrepresented in bacterial strains 
linked to IBD, its precise role in microbial-induced proinflammatory responses and subsequent 
disease development is unknown.  
 
We investigated the role of the Ybt-FyuA system in colitis utilizing a gnotobiotic Interleukin-10-
deficient (Il10-/-) mouse model, which is an inflammation susceptible germ-free (gf) mouse that will 
develop spontaneous colitis when colonized with bacteria and introduced to bacterial antigens (Figure 
1).12,13 Inactivation of the Ybt system had little impact on inflammation and colitis in Il10-/- mice. 
However, colonization with strains lacking the FyuA receptor, and thus unable to import Ybt, induced 
intestinal fibrosis. Colonization with strains incapable of Ybt biosynthesis attenuated the fibrotic 
development. This pathology required Ybt synthesis, but did not impact bacterial colonization and 
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was independent of Ybt uptake through FyuA, suggesting a novel mechanism for the siderophore 
system separate from its role in bacterial iron acquisition and fitness. Therefore, this data suggests 
that the bacterial small molecule Ybt promotes fibrosis in AIEC-colonized Il10-/- mice. 
Figure 1. In vivo Il10-/- (inflammation prone) gnotobiotic colitis model. 
 
Fig 1. Germ-free Il10-/- mice are mono-associated with isogenic mutant strains of E. coli NC101 deficient in various 
components of the Ybt-FyuA system. WT mice develop neither inflammation nor fibrosis in this model. FyuA encodes the 
FyuA receptor, and irp1 is required for Ybt biosynthesis. None of the three mutant strains can import Ybt in our mono-
association model. After 10 weeks of colonization, we harvest tissues for histologic and molecular analyses. My role was 
to evaluate disease in our cohort of fyuA irp1 colonized Il10-/- mice. 
 
Two fundamental questions were explored to evaluate the role of the Ybt-FyuA uptake system on 
IBD-associated fibrosis. To determine whether Ybt was essential for promoting fibrosis in E. coli 
NC101 fyuA (an AIEC strain unable to produce FyuA) mono-associated Il10-/- mice, germ-free mice 
were colonized with the NC101 fyuA irp1 (an AIEC strain unable to produce the FyuA receptor or 
Ybt siderophore) double-knockout strain. Mice mono-associated with NC101 fyuA irp1 
phenotypically mirrored mice colonized with NC101 irp1 in that both had intestinal inflammation, but 
no fibrosis. These results supported the hypothesis that Ybt is necessary for the development of the 
fibrotic phenotype. In order to further examine the molecular and cellular mechanisms implicated in 
fibrosis, the role of the E. coli Ybt-FyuA uptake system on fibroblast (cell type most likely responsible 
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for excess ECM deposition) activation was evaluated in vitro. Live E. coli NC101 strains missing 
various components of the Ybt-FyuA system were found incapable of directly stimulating fibroblasts. 
These negative results lead us to evaluate the activation potential of bacterial small molecules, 
including Ybt and various other metal chelators, on fibroblasts. Our findings support a model in which 
metal-chelating small molecules of the microbiota induce inflammation-associated fibrosis through 
indirect effects on fibroblast activation and subsequent ECM production.  
 
Materials and Methods 
 
Mice: Germ-free (GF) Il10-/- and WT mice of 129S6/SvEV background were originally derived and 
maintained under GF conditions at the National Gnotobiotic Rodent Resource Center at the 
University of North Carolina (UNC), Chapel Hill. All procedures were approved by the UNC 
Institutional Animal Care and Use Committee. 
 
In vivo mono-association of gnotobiotic mice with E. coli NC101 variant strains: An overnight 
bacterial culture of E. coli NC101 or NC101 fyuA irp1 mutant was utilized to monoassociate mice 
(age 8-11 weeks, n=15) via oral and rectal swab. Mice were maintained in gnotobiotic isolators for 10 
weeks. Necropsy was performed at 10 weeks post-colonization. Tissues were collected for 
histological analyses, and additional tissues were harvested and archived for molecular analyses.12,13 
Histologic and immunofluorescent (IF) analysis of tissue sections: At necropsy, colons were 
flushed of content, “Swiss rolled”, and fixed in 10% neutral buffered formalin. Intestinal pathology was 
assessed via H&E, Sirius Red, and Masson Trichrome staining of colon swiss rolls. Quantification 
and localization of activated fibroblasts and myofibroblasts was done using IF for smooth muscle 
actin (SMA) with the Translational Pathology Core (TPL) using Aperio software.  
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Bacterial Plating: Luminal (stool) and mucosally adherent (tissue) bacteria were quantified by serial 
dilution plating to evaluate colonization and determine bacterial load. 
  
Molecular Analysis: Tissue biopsies were analyzed by qPCR for fibroblast activation using the 
qPCR procedure outlined below.  
 
Bacterial strains and growth conditions for in vitro assays: The bacterial strains used in this 
study are listed in Table 1. All strains were created by the Arthur lab using the lambda-red 
recombinase method. Bacteria were grown aerobically overnight in shaker at 37C for all 
experiments. A bacterial inoculum of MOI 100 was prepared: An aliquot was taken from the culture 
for optical density (OD600) quantification by spectrometry or quantitative culture. The cultures were 
then centrifuged thoroughly, the cells were pelleted, and the remaining broth phase was removed by 
aspiration. The aggregate was re-suspended in phosphate-buffered saline (PBS). A 1:10 dilution in 
PBS was then taken for quantitative culture or spectrophotometry as a measure of the bacteria 
concentration of the whole culture. Concentration was calculated using the following formula 
[(OD(600) of 1)/(5x108 bacteria/mL)] x (A/x), where OD(600) is the optical density at 600 nm. 
Cell Culture: Swiss 3T3 cells were grown in Dulbecco’s Modified Eagle Medium (DMEM) 
supplemented with 10% heat inactivated fetal bovine serum (FBS) and 1% antibiotics (penicillin-
streptomycin) at 37C in a tissue culture incubator. Once confluent (~80%), cells were passaged 
using Trypsin/EDTA 0.05% and 3.0 x 105 cells/mL were split into a new T75 flask. 
 
Bacteria stimulation experiments: Six-well plates containing growth media (2 mL) were seeded 
with Swiss 3T3 cells at a concentration of 3.0 x 105 cells/well (~1 mL cells) and incubated at 37C for 
24 hours. Cells were then serum starved by replacing growth media with an equal volume of DMEM 
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supplemented with 0.1% heat inactivated FBS and incubated at 37C for 24 hours. Cells were 
stimulated with E. coli strains (Table 1) at MOI 100 for 4, 24, or 48 hours. Bacteria were killed after 4 
hours by aspirating media and replacing with an equal volume of recovery media (serum starve 
media supplemented with 200 ng/L gentamycin). PBS was added to cells to serve as a negative 
control. Cells were stimulated with TGF- (10 ng/L) or TGF- (50 ng/L) to serve as a positive 
control. Each stimulant was plated in duplicate or triplicate for all experiments. After collecting cell 
supernatants (1 mL), Swiss 3T3s were harvested in Trizol (1 mL) for RNA extraction. See Figure 2.  
Figure 2. Experimental design for in vitro fibroblast stimulations with bacteria. 
 
 
Siderophore stimulation experiments: Six-well plates were seeded with 3.0 x 105 Swiss 3T3 
cells/well into growth media (2 mL) and incubated at 37C for 24 hours. Cells were serum starved like 
above and incubated at 37C for 24 hours. Cells were stimulated as listed in Table 2 for 1, 4, 24, or 
48 hours. Each stimulant was assayed in duplicate or triplicate for all experiments. After collecting cell 






Figure 3. Experimental design for in vitro fibroblast stimulations with bacterial products, 
chelators and siderophores. 
 
 
RNA isolation and real-time qPCR analysis: RNA was extracted with Trizol according to 
manufacturer’s protocol. The purity of the RNA was evaluated by spectrophotometry using NanoDrop 
ND-1000 (Thermo Fisher) at a 260:280 and 260:230 ratio. cDNA was synthesized for real-time PCR 
(RT-qPCR) analysis. Total RNA (500 ng) was reverse transcribed using the qScript cDNA SuperMix 
(Quantabio). Quantitative real-time PCR was conducted using Sensifast SYBR No-ROX Kit (Bioline) 
on the Quant Studio 6 (Applied Systems) machine with the following conditions: 95C for 10 minutes, 
followed by 40 cycles at 95C for 15 seconds, 58C for 15 seconds, and 72C for 15 seconds. The 
expression of several fibrosis-associated genes (Table 3) was analyzed. The genes selected were 
known to be implicated in fibrotic processes. RT-qPCR SYBR green chemistry was used to quantitate 
the relative gene expression levels of the fibrotic factors: collagen-11, collagen-12, collagen-41, 
collagen-61, fibronectin, TGF-1, TGF- type II receptor, Slit3, and MMP-9. Relative expression was 
measured relative to gapdh housekeeping gene using the Ct method. 
Data analysis: In vivo experiments were performed reproducibly using two individual cohorts. For in 
















each sample being plated in triplicate each day (or duplicate due to lack of materials). Each gene was 
assayed in triplicate by RT-qPCR. Gene expression was normalized to gapdh and fold expression 
over unstimulated 3T3 fibroblasts was determined via the Ct method. The groups were compared 
using parametric tests only for normally distributed data, and multiple-comparison correction was 





Histopathological evidence of fibrosis occurred in a subset of NC101-colonized Il10-/- mice. 
While manipulation of the Ybt/FyuA system had a minimal impact on inflammation, a subset of fyuA-
colonized Il10-/- mice underwent distinct colonic remodeling, which was observed in haematoxylin and 
eosin (H&E) stained colon sections at 10 weeks (Fig. 4). The pathology was characterized by an 
expansion of the submucosa and deposition of wispy, fibrillar substances (Fig.4D). Because collagen 
is a characteristic feature of fibrotic tissues, we determined if collagen was present in regions of ECM 
deposition. Positive staining of the area by both Masson’s trichrome (Fig. 4F) and Sirius red (Fig. 4E) 
determined it was collagenous in nature. While the collagen matrix in the NC101 colons was 
structured and organized (Fig. 4B), the collagen in the fyuA colons was expanded and disorganized 
(Fig. 4E). To summarize, a subset of AIEC-colonized Il10-/- mice developed histopathological lesions 










Figure 4. Deletion of fyuA in NC101 E. coli promotes inflammation-associated fibrosis in Il10-/- 
mice. 
 
Fig 4. Histopathology of middle colons from Il10-/- mice colonized with either NC101 (A-C) or fyuA (D-F) stained with 
H&E (A, D), Sirius red (B ,E), and Trichrome (C, F). 10x objective magnification. Fibrotic pathology is characterized by 
submucosal hypertrophy (D, bracketed area). Fibrotic lesions in fyuA-colonized mice were positive for Trichrome and 
Sirius red staining, indicating collagen deposition within fibrotic tissues (E-F). Sirius red staining also revealed a basal 
predilection of collagen in fyuA-colonized mice versus an apical propensity in NC101-colonized non-fibrotic mice (B, E, 
black arrowheads).  
 
Colonization with fyuA-deficient E. coli NC101 promotes inflammation-associated fibrosis that 
is associated with a distinct pro-fibrotic colonic transcriptional gene signature. Fibrosis was 
most severe in fyuA-colonized mice (Fig. 5A-B). Since variations in fibrosis severity could be caused 
by different host responses to the different bacterial strains, we conducted high-throughput RNA 
sequencing to determine whether global differences were apparent in the colonic transcriptomes of 
inflamed Il10-/- and non-flamed WT mice colonized with NC101 or fyuA (pro-fibrotic strain). Principal 
Coordinate Analysis (PCoA) revealed significant differences in the colonic transcriptomes of NC101 
versus fyuA-colonized Il10-/- mice at 10 weeks. Gene-level and pathway analysis revealed 2692 
genes that were differentially expressed between fyuA-colonized fibrotic Il10-/- mice versus NC101-
colonized Il10-/- mice at 10 weeks (Fig. 6). The most highly upregulated gene ontogeny pathway was 
extracellular matrix with a magnitude of perturbation of 7.4 (Fig. 6). Differential expression of this 
pathway was not evident in WT mice, nor was fibrosis. Together these results demonstrate we have 
developed a new animal model for IBD-associated fibrosis, with fibrosis confirmed via histologic and 






Figure 5. Yersiniabactin biosynthesis promotes fibrosis in AIEC-driven colitis. 
 
 
Fig 5. Fibrosis incidence rates in Il10-/- mice monoassociated with NC, fyuA, irp1, or fyuA irp1 for 10 weeks as 
assessed by H&E histology (a-c). The Ybt-positive group includes Il10-/- mice colonized with NC or fyuA. The Ybt-
negative group includes Il10-/- mice colonized with irp1 or fyuA irp1. Composite fibrosis histology scores at 10 weeks 
(d). Each symbol represents an individual mouse (n = 11-29).  
 
Figure 6. Colon tissue with fibrotic pathology had a significantly different host gene signature 
as assessed by RNAseq.  
 
Fig 6. RNAseq was performed on host RNA isolated from proximal colon tissue. Principle coordinate analysis reveals 
transcriptome-wide changes in the colons of E. coli NC101 vs. NC101fyuA colonized WT and Il10-/- mice 10 weeks post-




Yersiniabactin biosynthesis is necessary for induction of inflammation-associated fibrosis. 
The FyuA receptor is responsible for the import of Ybt-metal complexes as part of the Ybt 
siderophore system. We hypothesized that disruption of Ybt uptake contributed to the pro-fibrotic 
potential of NC101fyuA, and that colonization with a Ybt-deficient strain, NC101irp1, would also 
induce fibrosis. To determine if inactivation of Ybt biosynthesis would also promote induction of 
fibrosis, the irp1 mutant was generated which prevents the biosynthesis of Ybt. Surprisingly, only 
18.2% of irp1 mice developed histological evidence of fibrosis compared to 58.6% of fyuA-
colonized mice (Fig. 5a). Next, the fyuA irp1 mutant was generated to confirm that Ybt biosynthesis 
was required for the development of fibrosis. The fyuA irp1 mutant also decreased the incidence of 
fibrosis with only 6.7% of mice showing evidence of fibrosis (Fig. 5a). Taken together (Fig. 5), these 
data demonstrate that Ybt biosynthesis is required for pro-fibrotic activity, but independent of its 
uptake through FyuA. 
 
Live E. coli and its Ybt-FyuA uptake system do not stimulate fibroblast activation in vitro. 
Because RNAseq analysis revealed the ECM pathways to be the most differentially regulated gene 
ontogeny category (Fig. 6), we next tested whether bacteria could directly and differentially activate 
fibroblasts. We developed an in vitro co-culture model of Swiss 3T3 fibroblasts and NC101 E. coli 
followed by qPCR analysis of pro-fibrotic genes expressed during fibroblast activation. We performed 
extensive optimization of this in vitro assay before evaluating the impact of the E. coli Ybt/FyuA 
system on fibroblasts (optimization data not shown). Stimulation at 4, 24, and 48-hour time-points 
(Fig. 7A-C) revealed the E. coli strains were incapable of directly activating fibroblasts when 
compared to the positive control TGF- (10ng/L). From this, we concluded that live E. coli are 
unlikely to directly activate fibroblasts in our inflammation-associated colitis model.  
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Fig 7. Swiss 3T3 fibroblasts were stimulated with the indicated FyuA/Ybt variant E. coli NC101 strains at MOI 100. 
Extracellular bacteria were killed off at 4 hours with Gentamycin. Cells were harvested after 4 (A), 24 (B), or 48 (C) hours 
and collected in Trizol to extract RNA. Relative gene expression was quantified via RT-qPCR utilizing SYBR green 
chemistry. Genes were normalized to the housekeeping gene Gapdh using ∆∆Ct method. Each symbol represents a 
biological replicate (independent experiment) plated in triplicate (within each independent experiment). Lines are at the 
mean. 
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Fibroblasts are unlikely to be directly stimulated by bacteria or bacterial products. Because we 
found live E. coli incapable of directly activating fibroblasts, we next examined whether bacterial 
products that enter intestinal tissues during inflammation were capable of fibroblast activation. This 
seemed a plausible next step because, in contrast to intestinal epithelial cells and macrophages, 
intestinal fibroblasts rarely encounter live bacteria, but could encounter their bacterial products. 
Specifically, we chose to evaluate the effects of the Ybt siderophore and the chelators TPEN, DTPA, 
and BPD (Table 2).  
 
To do this, we developed an in vitro co-culture model of Swiss 3T3 fibroblasts and bacterial products 
followed by qPCR analysis of pro-fibrotic genes expressed during fibroblast activation. We performed 
extensive optimization of this in vitro assay before evaluating the impact of the siderophore and 
chelators on fibroblasts (optimization data not shown). 
 
Gene expression of col4a1 and Fn1 was increased by DTPA after 4 hours (Fig. 8B, red symbols). It is 
possible that DTPA also increased the expression of collagens and fibronectin at 24 and 48 hours 
(Fig. 8C-D, green symbols), but additional experiments would be required to determine if this 
conclusion is statistically valid. At 24 and 48 hours, both TPEN and Ybt stimulated fibroblasts showed 
visible evidence of cellular death at harvest, which was further substantiated by low gene expression 
values (Fig. 8C-D, blue symbols). TPEN and DTPA are both metal chelators with differing specificities 
for biologically relevant metals; TPEN has a high binding specificity for Zn2+, while DTPA is more 
promiscuous and binds Fe3+, Cu2+, Ga2+, and more (TPEN, DTPA). The Arthur lab is further 













Figure 8. Swiss 3T3 fibroblasts were stimulated with Ybt and various chelators in the concentrations indicated. Cells were 
harvested after 1 (A), 4 (B), 24 (C), or 48 (D) hours and collected in Trizol for RNA extraction. Relative gene expression 
was quantified via RT-qPCR utilizing Sybr green chemistry. Genes were normalized to the housekeeping gene Gapdh 
using ∆∆Ct method. Each symbol represents a biological replicate plated in triplicate. Lines are at the mean. Red symbols 
indicate a statistical difference calculated via t-test (p<0.05). Blue symbols indicate evidence of substantial cell death at 




Fibrosis afflicts more than 30% of patients with IBD, yet there is no cure and few, inadequate 
treatment options. One major reason is due to lack of animal models. We have developed an 
inflammation-associated fibrosis animal model, which will permit further research and lead to the 
development of new treatment options.  
 
Recent studies have implicated the importance of perturbations of the gut microbiota in the onset of 
IBD. Now, we have linked a pathobiont of the gut microbiota (E. coli NC101) to the development of 
IBD-associated fibrosis. Moreover, our findings substantiate that we may have linked a bacterial small 
molecule (Ybt) from the gut microbiota to fibrosis. As many gut bacteria are capable of producing 
siderophores and metallophores, such findings could be extended to multiple microbial-associated 
impacts on human health and disease.  
 
In vivo studies revealed a subset of Il10-/- mice monoassociated with NC101 fyuA developed a 
fibrotic pathology. This indicates Ybt may favor the development of fibrotic IBD over inflammatory 
IBD. The attenuation of fibrotic development by the irp1 mutant demonstrated the fibrotic phenotype 
was not driven by the inability to import Ybt. Further abrogation of the pathology by the fyuA irp1 
mutant indicated Ybt biosynthesis was required to induce fibrosis. This, along with no evidence of 
differences in host or bacterial iron homeostasis, suggests a novel mechanism for the Ybt 
siderophore system in addition to its role in iron chelation. Thus, we have demonstrated uncoupling of 
biosynthesis and uptake of the Ybt siderophore. 
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In vitro studies revealed that neither WT NC101 E. coli nor its isogenic mutants were capable of 
directly activating fibroblasts. While these experiments failed to identify a cell-type targeted by 
bacteria, they prompted us to investigate the impact of bacterial products on fibroblast activation.  
 
Stimulation of fibroblasts with the chelator DTPA demonstrated a potential increase in the expression 
of collagen and fibronectin, which are hallmark genes of fibrosis and formation of the ECM. This 
suggests that the in vivo disease phenotype might function mechanistically similar to DTPA metal 
chelation. DTPA is a promiscuous chelator capable of binding iron, copper, nickel, zinc, and others. 
Ybt can also bind these biologically important metals at varying affinities.  
 
In vitro stimulations repeatedly showed that excessive Zn2+ chelation via TPEN caused fibroblast cell 
death. Stimulation with Ybt (5M) showed a similar gene expression profile to TPEN at 24 and 48 
hours, which are the same time-points that show evidence of TPEN-induced cell death. Taken 
together, this suggests that excessive Zn2+ chelation causes the death of fibroblasts. The Arthur lab is 
currently performing additional studies to titrate Ybt and chelators in fibroblasts, intestinal epithelial 
cells, and macrophages.  
 
At present, the impact of bacterial products on fibroblasts remains unclear. However, our findings 
have provided considerable evidence for ruling out the direct stimulation of fibroblasts as part of the 
mechanism involved in fibrogenesis. We therefore have decided to focus future studies on other cell 
types that could be impacting fibroblast activation, such as macrophages. Current and future studies 
will evaluate how the NC101 Ybt-FyuA system impacts macrophage function, including M1/M2 












NC101 WT yes yes 
NC101 fyuA yes no 
NC101 irp1 no yes 
NC101 fyuA irp1 no no 
 
Table 2. Bacterial small molecules used in this study.14,15,16  
Small Molecule Mechanism 
Diethylenetriaminepentaacetic acid (DTPA) Promiscuous chelator 
N,N,N′,N′-Tetrakis(2-pyridinylmethyl)-1,2-ethanediamine (TPEN) Zinc chelator 
2,2′‐bipyridyl (BPD) Iron chelator 
Yersiniabactin (Ybt) Experimental siderophore 
Transforming growth factor 1 (TGF-) Master regulator of fibrosis 
 
Table 3. Oligonucleotide primers used in this study. 
Name Forward Primer (5’ to 3’) Reverse Primer (5’ to 3’) Function 
gapdh GGTGAAGGTCGGAGTCAACGGA GAGGGATCTCGCTCCTGGAAGA housekeeping 
gene 
mCol1a1 TGACTGGAAGAGCGGAGAGT ATCCATCGGTCATGCTCTCT type I 
collagen 
mCol1a2 AGGCCCAACCTGTAAACACC CTGAGAAGCACGGTTGGCTA type II 
collagen 
mCol4a1 CACAGTCAGACCATTCAGATTC CGGAACCTTCAGCACCAG type IV 
collagen 
mCol6a1 CTGCTGGTGAGAATGGATGGTGT TGTGCCGAGTCATAGCCGAATAG type VI 
collagen 
mFn1_ CCAACTCCTTGCTGGTGTCA GAGAGCTTCCTGTCCTGTCT fibronectin 
(ECM 
component) 
mTgfb1_ TCTCTGTGGAGCTGAAGCAA TGAGTGGCTGTCTTTTGACG master 
regulator of 
fibrosis 
mTgfbr2 AGCATCACGGCCATCTGTG TGGCAAACCGTCTCCAGAGT TGF- 
receptor 
Slit3 GCTTGTGCACCATGGCCC CTCTCCAGCTGCTTCAGATC 3T3 activation 
gene 
mMmp-9 CCTTGGTGTAGCACAACAGC ATACTGGATGCCGTCTATGTCG  
*These genes have been identified as being differentially regulated in vivo by the Arthur Lab’s RNA-
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